结合人工智能与 Lung-RADS 的基线肺癌筛查肺结节管理策略的开发与成本分析
该研究对 192 例基线低剂量 CT 的 AI 恶性风险评分与 6 名放射科医生的 Lung-RADS 分类进行二次分析,并加权建模 3,197 例基线筛查患者。将高 AI 风险的 Lung-RADS 1/2 类升级为 3 类、低 AI 风险的 3 类及以上降级为 2 类后,AI 策略敏感度 91%、特异度 96%,而 6 名医生单用 Lung-RADS 的平均敏感度 91%、特异度 66%,每例筛查患者最低净节省 72 美元。
要点
- AI 风险评分联合 Lung-RADS 策略的敏感度 91%、特异度 96%,与医生单用 Lung-RADS 的平均敏感度 91% 相同,但特异度由 66% 提高至 96%。
- 采用 AI 策略后,41 例(0.2%)初始 Lung-RADS 1 或 2 类被升级为 3 类,5,750 例(30%)初始 3 类及以上被降级为 2 类。
- AI 策略每例筛查患者最低净节省 72 美元,可能减少随访检查次数。
核心结论
- 在基线肺癌筛查中,将 AI 风险评分与 Lung-RADS 联合使用可能减少随访检查并带来可观的成本节省。
研究设计与样本
- 对 192 例基线低剂量 CT 的 AI 恶性风险评分与 6 名放射科医生 Lung-RADS 分类进行二次分析,并加权建模 3,197 例代表性基线筛查患者。
诊断标准与关键数值
- AI 风险评分阈值定义为匹配 6 名放射科医生应用 Lung-RADS 的平均敏感度;AI 策略的敏感度 91%、特异度 96%,6 名医生单用 Lung-RADS 的平均敏感度 91%、特异度 66%。
临床应用与阅片要点
- AI 策略将初始 Lung-RADS 1 或 2 类且 AI 高风险者升级为 3 类,将初始 3 类及以上且 AI 低风险者降级为 2 类,随访检查费用基于 2019 年美国 Medicare 医师费用表。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop a lung nodule management strategy combining the Lung CT Screening Reporting and Data System (Lung-RADS) with an artificial intelligence (AI) malignancy risk score and determine its impact on follow-up investigations and associated costs in a baseline lung cancer screening population.
MATERIALS AND METHODS: Secondary analysis was undertaken of a data set consisting of AI malignancy risk scores and Lung-RADS classifications from six radiologists for 192 baseline low-dose CT studies. Low-dose CT studies were weighted to model a representative cohort of 3,197 baseline screening patients. An AI risk score threshold was defined to match average sensitivity of six radiologists applying Lung-RADS. Cases initially Lung-RADS category 1 or 2 with a high AI risk score were upgraded to category 3, and cases initially category 3 or higher with a low AI risk score were downgraded to category 2. Follow-up investigations resulting from Lung-RADS and the AI-informed management strategy were determined. Investigation costs were based on the 2019 US Medicare Physician Fee Schedule.
RESULTS: The AI-informed management strategy achieved sensitivity and specificity of 91% and 96%, respectively. Average sensitivity and specificity of six radiologists using Lung-RADS only was 91% and 66%, respectively. Using the AI-informed management strategy, 41 (0.2%) category 1 or 2 classifications were upgraded to category 3, and 5,750 (30%) category 3 or higher classifications were downgraded to category 2. Minimum net cost savings using the AI-informed management strategy was estimated to be $72 per patient screened.
CONCLUSION: Using an AI risk score combined with Lung-RADS at baseline lung cancer screening may result in fewer follow-up investigations and substantial cost savings.
引用
- Adams SJ, Mondal P, Penz E, et al. Development and Cost Analysis of a Lung Nodule Management Strategy Combining Artificial Intelligence and Lung-RADS for Baseline Lung Cancer Screening. J Am Coll Radiol. 2021. PMID: 33482120. doi:10.1016/j.jacr.2020.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。